World Bulletin/News Desk
The World Health Organization has endorsed using HIV medicines among people who do not have the infection but are at high risk of getting it, and suggested that poor and wealthy countries alike set up pilot projects to better understand the benefits.
The United Nations agency made its suggestion on Friday, four days after U.S. regulators approved use of Gilead Sciences Inc's Truvada for people who are not infected but may engage in sexual activity with HIV-positive partners. The concept is known as pre-exposure prophylaxis (PrEP).
Truvada, which combines the anti-HIV drugs tenofovir and emtricitabine in one pill, is widely used to treat people already infected with the virus that causes AIDS. The medicine, which costs almost $14,000 a year in the United States, is the first treatment also approved for prevention.
"WHO is encouraging countries wishing to introduce PrEP to first establish small projects to help public health workers to better understand and realize its potential benefits," the agency said in a statement. It said appropriate HIV medicines should be given to those at high risk of infection.
"These could include men or transgender women who have sex with men," the group said.
WHO spokeswoman Sarah Russell said the agency could not recommend specific drugs for prevention, but she said, "It needs to be a drug like Truvada that has been developed for prevention purposes."
Russell said WHO expects Gilead to make Truvada available at a deeply discounted price in some poor countries.
"We believe Gilead will bring the price down to about $100 per year per person" in those countries, she said in an interview.
Gilead officials could not immediately be reached for comment.
WHO noted that an international study called Partners PrEP has shown that HIV medicines are highly effective at preventing the illness in men and women whose partners are infected.
That study, conducted in Kenya and Uganda and funded by the Bill & Melinda Gates Foundation, involved taking a daily tablet containing tenofovir or tenofovir in combination with emtricitabine.
The U.N. agency said it would evaluate the outcomes of the small projects, along with evolving scientific evidence, before issuing its own detailed guidelines next year on the use of HIV treatments for prevention.
WHO said it was important that people taking HIV drugs for prevention are HIV-negative because otherwise drug resistant forms of HIV could evolve. The agency said they should also continue using condoms and faithfully take their medicines on a daily basis.
The outbreak of myiasis, also known as screw worm, stems from deteriorating water and sanitation conditions.
The incursion largely follows water currents north from the Red Sea. Already more than 700 non-indigenous species have populated the Mediterranean
Joji Morishita, Japan's commissioner to the International Whaling Commission, said the new proposal is Tokyo's latest attempt to pursue sustainable whaling according to scientific principles.
In Europe, obesity is to blame for around 6.5 percent of all new cancers a year, or around 65,000 cases
Medical workers risking their lives to fight Ebola in West Africa talk about the challenges they face.
The woman 32, died at a fever hospital in the Nile Delta five days after she was admitted on contracting the virus, Hossam Abdel-Ghafar said
According to the World Health Organization, more than 80,000 children in Pakistan have not been immunized against polio
A total of 5,459 people have died in the worst Ebola outbreak on record, according the World Health Organization
Plague, a bacterial disease, is mainly spread from one rodent to another by fleas.
Felix Baez Sarria, the first Cuban to contract the deadly disease, will be treated in a Geneva hospital.
No Ebola cases detected for two incubation periods, says World Health Organization
The World Health Organization and leading global health specialists have criticised Saudi Arabia for failing to properly investigate the causes of MERS.
UNICEF predicts that the number of children orphaned by Ebola – which currently stands at nearly 200 – will reach as many as 2,000
UN Article 82 could mean millions in additional costs for drilling companies.
The figures, through Nov. 16, represent a jump of 243 deaths and 732 cases since those issued last Friday, and cases continue to be under-reported, the WHO said in its latest update.
The infectious disease causes total paralysis in a matter of hours. It affects mainly children under five years of age.